Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

A Decision Analysis of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients with De-Novo Myelodysplastic Syndrome (MDS): Early Transplantation Offers Survival Benefit in Higher-Risk MDS

Blood (2011) 118 (21): 115.

https://doi.org/10.1182/blood.V118.21.115.115

Published: 2011

Journal Articles

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells

Andrea Pellagatti, Mario Cazzola, Aristoteles Giagounidis, Janet Perry, Luca Malcovati, Matteo G. Della Porta, Martin Jädersten, Sally Killick, Paresh Vyas, Eva Hellström-Lindberg, Jacqueline Boultwood, James S. Wainscoat

Blood (2010) 116 (21): 298.

https://doi.org/10.1182/blood.V116.21.298.298

Published: 2010

Journal Articles

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells.

Andrea Pellagatti, Mario Cazzola, Aristoteles Giagounidis, Janet Perry, Luca Malcovati, Matteo G Della Porta, Martin Jädersten, Sally Killick, Amit Verma, MD, Eva Hellström-Lindberg, James S Wainscoat, Jacqueline Boultwood

Blood (2009) 114 (22): 735.

https://doi.org/10.1182/blood.V114.22.735.735

Published: 2009

Journal Articles

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia.

Jacqueline Boultwood, Janet Perry, Andrea Pellagatti, Aristoteles Giagounidis, Luca Malcovati, Matteo G Della Porta, Martin Jädersten, Sally Killick, Eva Hellström-Lindberg, Mario Cazzola, James S Wainscoat

Blood (2009) 114 (22): 419.

https://doi.org/10.1182/blood.V114.22.419.419

Published: 2009

Journal Articles

Clonal Heterogeneity in the 5q- Syndrome: NPMc+ and p53 Expressing Progenitors Are Insensitive to Lenalidomide Treatment and Expand at Disease Progression

Martin Jädersten, Leonie Saft, Andrea Pellagatti, Gudrun Göhring, Cristina Fernández-Santamaria, James S Wainscoat, Jacqueline Boultwood, Anna Porwit, Brigitte Schlegelberger, Eva Hellström-Lindberg, MD, PhD

Blood (2008) 112 (11): 5104.

https://doi.org/10.1182/blood.V112.11.5104.5104

Published: 2008

Journal Articles

Haploinsufficiency of RPS14 and Deregulation of Ribosomal- and Translation-Related Genes in MDS Patients with Del(5q)

Andrea Pellagatti, Eva Hellström-Lindberg, Aristoteles Giagounidis, Janet Perry, Luca Malcovati, Matteo Della Porta, Martin Jädersten, Sally Killick, Davendra P. Sohal, Amit Verma, Mario Cazzola, James S. Wainscoat, Jacqueline Boultwood

Blood (2008) 112 (11): 3641.

https://doi.org/10.1182/blood.V112.11.3641.3641

Published: 2008

Journal Articles

Gene Expression Profiling of CD34 + Cells in Patients with Myelodysplastic Syndromes

Andrea Pellagatti, Mario Cazzola, Aristoteles Giagounidis, Janet Perry, Luca Malcovati, Matteo Della Porta, Martin Jädersten, Sally Killick, Eva Hellström-Lindberg, James S. Wainscoat, Jacqueline Boultwood

Blood (2008) 112 (11): 3642.

https://doi.org/10.1182/blood.V112.11.3642.3642

Published: 2008

Journal Articles

Gene Expression Profiling of Day 7 Erythroblasts from RARS Before and after Treatment with G-CSF.

Maryam Nikpour, MSc, Andrea Pellagatti, PhD, Martin Jädersten, MD, Ann-Mari Forsblom, James S. Wainscoat, MD, Jacqueline Boultwood, PhD, Eva Hellström-Lindberg, MD, PhD

Blood (2007) 110 (11): 2427.

https://doi.org/10.1182/blood.V110.11.2427.2427

Published: 2007

Journal Articles

Expression Profiling of CD34+ Cells in Patients with Myelodysplastic Syndromes: Involvement of Interferon-Stimulated Genes and Correlation to FAB Subtype and Karyotype.

Andrea Pellagatti, Mario Cazzola, Aristoteles Giagounidis, Luca Malcovati, Matteo G. Della Porta, Martin Jädersten, Sally Killick, Carrie Fidler, David Oscier, David Bowen, Carlo Aul, Eva Hellström-Lindberg, James S. Wainscoat, Jacqueline Boultwood

Blood (2006) 108 (11): 2626.

https://doi.org/10.1182/blood.V108.11.2626.2626

Published: 2006

Journal Articles

Lenalidomide Up-Regulates SPARC and Inhibits In Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome Patients with 5q Deletion.

Andrea Pellagatti, Martin Jädersten, Ann-Mari Forsblom, Helen Cattan, Birger Christensson, Emma K. Emanuelsson, Mats Merup, Lars Nilsson, Jan Samuelsson, Birgitta Sander, James S. Wainscoat, Jacqueline Boultwood, Eva Hellström-Lindberg

Blood (2006) 108 (11): 855.

https://doi.org/10.1182/blood.V108.11.855.855

Published: 2006

Journal Articles

Treatment with Erythropoietin and G-CSF Improves Survival in MDS Patients with Low Transfusion Need.

Martin Jädersten, MD, Luca Malcovati, MD, Ingunn Dybedal, MD, Matteo Giovanni Della Porta, MD, Rosangela Invernizzi, MD, Scott M. Montgomery, PhD, Cristiana Pascutto, Anna Porwit-MacDonald, MD, Mario Cazzola, MD, Eva Hellström-Lindberg, MD, PhD

Blood (2006) 108 (11): 521.

https://doi.org/10.1182/blood.V108.11.521.521

Published: 2006

Journal Articles

Lenalidomide Selectively Inhibits In Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome (MDS) Patients with 5q Deletion.

Martin Jädersten, MD, Andrea Pellagatti, Ann-Mari Forsblom, Emma K. Emanuelsson, Mats Merup, MD, Jan Samuelsson, MD, James S. Wainscoat, Jacqueline Boultwood, Eva Hellström-Lindberg, MD

Blood (2005) 106 (11): 3438.

https://doi.org/10.1182/blood.V106.11.3438.3438

Published: 2005

Journal Articles

Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF

Martin Jädersten, Scott M. Montgomery, Ingunn Dybedal, Anna Porwit-MacDonald, Eva Hellström-Lindberg

Blood (2005) 106 (3): 803–811.

https://doi.org/10.1182/blood-2004-10-3872

Published: 2005

NARROW

A Decision Analysis of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients with De-Novo Myelodysplastic Syndrome (MDS): Early Transplantation Offers Survival Benefit in Higher-Risk MDS

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells.

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia.

Clonal Heterogeneity in the 5q- Syndrome: NPMc+ and p53 Expressing Progenitors Are Insensitive to Lenalidomide Treatment and Expand at Disease Progression

Haploinsufficiency of RPS14 and Deregulation of Ribosomal- and Translation-Related Genes in MDS Patients with Del(5q)

Gene Expression Profiling of CD34 + Cells in Patients with Myelodysplastic Syndromes

Gene Expression Profiling of Day 7 Erythroblasts from RARS Before and after Treatment with G-CSF.

Expression Profiling of CD34+ Cells in Patients with Myelodysplastic Syndromes: Involvement of Interferon-Stimulated Genes and Correlation to FAB Subtype and Karyotype.

Lenalidomide Up-Regulates SPARC and Inhibits In Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome Patients with 5q Deletion.

Treatment with Erythropoietin and G-CSF Improves Survival in MDS Patients with Low Transfusion Need.

Lenalidomide Selectively Inhibits In Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome (MDS) Patients with 5q Deletion.

Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only